VENTURE CAPITAL POST

Moderna expands its vaccine portfolio with three new candidates targeting norovirus, Epstein-Barr virus, and shingles amid demand for Covid-19 vaccines worldwide.

Self.made billionaire Sean Parker continues his vision on advancing medical researches. His Parker Institute for Cancer Immunotherapy collaborated with the Cancer Research Institute in an effort to use algorith in uncovering neoantigens.

The president of Russia, Vladimir Putin, announced that his country had found two vaccines to cure Ebola. However, the announcement has drawn some skepticism among experts who have previously developed other vaccines for Ebola.

Two tiny companies are preparing to challenge some of the world's largest drug makers in the battle for dominance in the $3 billion global market for influenza vaccines, armed with little more than tiny tobacco plants.

Hookipa Biotech AG, whose Vaxwave Technology, would help in the furtherance of infectious disease control and cancer management.

immatics raises EUR34 million in its latest Series D round financing.